IOP: Clinical Trials

5 trials for IOP, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 2 unknown. 2 Not applicable, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Not applicable2Completed 1, Unknown 1
Phase 21Completed 1

Follow IOP: new trials by email Literature Review of IOP trials Research Report on IOP

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
24-hour Wear Performance and Safety Study of Smartlens miLens Contact Lens for IOP Monitoring
miLens system - Glaucoma, GLAUCOMA 1, OPEN ANGLE, D (Disorder)
CompletedSmartlens, Inc.862025-02-192026-04-01
Long-term Safety and Effectiveness of LASIK-Xtra Compared to Conventional LASIK
Tomography, Corneal Biomechanics
UnknownUniversity Clinic Frankfurt122024-08-012025-03-04
Safety, Tolerability and Preliminary Efficacy of Unilateral Latanoprost-loaded Punctual Plug -EXP-LP
drug delivery system, XALATAN® - Glaucoma, Ocular Hypertension
Not applicableUnknownShaare Zedek Medical Center402018-06-012017-11-28
Bisphosphonates for Prevention of Post-Denosumab Bone Loss
Alendronate, Zoledronic Acid - IOP, Osteoporosis
Phase 2CompletedColumbia University242018-01-292024-05-08
Effect of Acetazolamide on Intraocular Pressure After Being in the Trendelenburg Position.
Acetazolamide, Placebo, Trendelenburg Position - IOP
Not applicableCompletedUniversity of Nottingham92015-03-012017-04-11

Narrower conditions

Glaucoma (2)  ·  Ocular Hypertension (2)  ·  Glaucoma, Open-Angle (1)  ·  Lacrimal Duct Obstruction (1)  ·  Low Tension Glaucoma (1)  ·  Osteoporosis (1)

Broader conditions

Eye Diseases (2)  ·  Bone Diseases (1)  ·  Bone Diseases, Metabolic (1)  ·  Lacrimal Apparatus Diseases (1)  ·  Metabolic Diseases (1)  ·  Musculoskeletal Diseases (1)  ·  Nutritional and Metabolic Diseases (1)  ·  Optic Nerve Diseases (1)

Interventions

Acetazolamide (1)  ·  Alendronate (1)  ·  Drug Delivery Systems (1)  ·  Head-Down Tilt (1)  ·  Latanoprost (1)  ·  Zoledronic Acid (1)

Sponsors

Columbia University (1)  ·  Shaare Zedek Medical Center (1)  ·  Smartlens, Inc. (1)  ·  University Clinic Frankfurt (1)  ·  University of Nottingham (1)

Countries

United States (2)  ·  Germany (1)  ·  Israel (1)

Top investigators

Elizabeth Shane, MD (1)  ·  Ishay Attar, CEO (1)  ·  Parveen Vitish-Sharma, MRCS MSc (1)  ·  Tal Lavi (1)  ·  Thomas Kohnen, Professor and Doctor (1)

Results publications

PMID 21399724, PMID 22607109, PMID 22972069, PMID 23420235, PMID 23881267, PMID 25383466, PMID 25533656, PMID 31678559, PMID 41392041